About the Authors
- Manica Balasegaram
-
Affiliation Médecins Sans Frontières, Geneva, Switzerland
- Peter Kolb
-
Affiliation Department of Pharmaceutical Chemistry, Philipps-University Marburg, Marburg, Germany
- John McKew
-
Current address: Lumo Pharma, Austin, Texas, United States of America
Affiliation National Institutes of Health, National Center for Advancing Translational Sciences (NCATS), Bethesda, Maryland, United States of America
- Jaykumar Menon
-
Affiliation McGill University Institute for the Study of International Development, Montreal, Canada
- Piero Olliaro
-
Affiliations UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva, Switzerland, Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom
- Tomasz Sablinski
-
Affiliation Transparency Life Sciences, New York, New York, United States of America
- Zakir Thomas
-
Current address: Directorate of Risk Assessment, Government of India, New Delhi, India
Affiliation Open Source Drug Discovery, Council of Scientific and Industrial Research (CSIR), New Delhi, India
- Matthew H. Todd
-
* E-mail: matthew.todd@sydney.edu.au
Affiliation School of Chemistry, The University of Sydney, Sydney, Australia
- Els Torreele
-
Affiliation Public Health Program, Open Society Foundations, New York, New York, United States of America
- John Wilbanks
-
Affiliation Sage Bionetworks, Seattle, Washington, United States of America
Competing Interests
TS is CEO and founder of Transparency Life Sciences and an employee of Auven Therapeutics, as well as owning equity in biotech companies. JM and MHT were members of a group that received a grant from Tata Trusts (India) in 2015 to establish the Open Source Pharma Foundation, a not-for-profit agency working in India to support open source drug discovery initiatives worldwide, in part by advocating the potential public health benefits of such initiatives. The Foundation was formally created in 2016 but has not at the time of writing begun operations. ZT was Project Director of the Open Source Drug Discovery Project, CSIR, India. MHT is founder of the Open Source Malaria Consortium. These are non-profit, government-led initiatives pursuing open models of drug discovery and development.